ROHAN PALEKAR - 30 Jun 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol
ETNB
Transactions as of
30 Jun 2023
Net transactions value
-$313,187
Form type
4
Filing time
05 Jul 2023, 20:39:04 UTC
Previous filing
09 Jun 2023
Next filing
21 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +33,334 +12% $0.000000 321,978 30 Jun 2023 Direct F1, F2
transaction ETNB Common Stock Tax liability $313,187 -16,527 -5.1% $18.95 305,451 30 Jun 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives.
F2 Includes an aggregate of 1,666 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on June 30, 2023.
F3 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.